Amphastar Pharmaceuticals
AMPH
AMPH
136 hedge funds and large institutions have $489M invested in Amphastar Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 55 increasing their positions, 38 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
17% less capital invested
Capital invested by funds: $591M → $489M (-$102M)
82% less call options, than puts
Call options by funds: $203K | Put options by funds: $1.11M
Holders
136
Holding in Top 10
–
Calls
$203K
Puts
$1.11M
Top Buyers
| 1 | +$5.46M | |
| 2 | +$2.95M | |
| 3 | +$2.63M | |
| 4 |
Two Sigma Investments
New York
|
+$2.54M |
| 5 |
Goldman Sachs
New York
|
+$1.96M |
Top Sellers
| 1 | -$7.8M | |
| 2 | -$4.89M | |
| 3 | -$2.97M | |
| 4 |
Bessemer Group
Woodbridge,
New Jersey
|
-$2.51M |
| 5 |
Renaissance Technologies
New York
|
-$2.49M |